Genedx Holdings Corp (WGS)

Jan 17, 2025, 4:30 PM EST - 10 hours ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 16, 2025, 2:03 AM EST - 2 days ago

GeneDx Holdings: A Phenomenal Comeback With More Room To Run

Jan 13, 2025, 8:30 AM EST - 4 days ago

GeneDx Announces Preliminary 2024 Financial Results

Jan 9, 2025, 8:30 AM EST - 8 days ago

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

Jan 8, 2025, 8:30 AM EST - 9 days ago

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

Jan 2, 2025, 11:46 PM EST - 15 days ago

Best-Performing Stocks Of 2024

APP BYRN CADL DAVE INOD JANX LUNR

Jan 2, 2025, 4:01 PM EST - 15 days ago

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer

Dec 16, 2024, 4:05 PM EST - 4 weeks ago

GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 5, 2024, 8:30 AM EST - 6 weeks ago

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

BIIB PRAX STOK

Nov 22, 2024, 4:05 PM EST - 2 months ago

GeneDx to Participate in Upcoming Investor Conference

Nov 19, 2024, 8:30 AM EST - 2 months ago

GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

Nov 18, 2024, 8:30 AM EST - 2 months ago

GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary

Nov 7, 2024, 4:35 PM EST - 2 months ago

New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields

Nov 4, 2024, 4:35 PM EST - 2 months ago

GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 31, 2024, 6:11 PM EDT - 2 months ago

Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds

Oct 30, 2024, 3:10 PM EDT - 2 months ago

GeneDx Holdings: Phenomenal Gains, More Upside Potential In Medium Term

Oct 29, 2024, 6:46 PM EDT - 2 months ago

GeneDx Holdings Corp. (WGS) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 11:11 AM EDT - 2 months ago

Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance

Oct 29, 2024, 8:00 AM EDT - 2 months ago

GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights

Oct 24, 2024, 11:10 AM EDT - 3 months ago

Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening

Oct 21, 2024, 10:00 AM EDT - 3 months ago

GeneDx Holdings: Stock To Keep Outperforming As Business Momentum Persists

Oct 8, 2024, 8:30 AM EDT - 3 months ago

GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns

Oct 3, 2024, 4:05 PM EDT - 3 months ago

GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024

Aug 19, 2024, 7:58 AM EDT - 5 months ago

GeneDx Holdings: Profits On The Horizon For AI Driven Health Platform

Aug 12, 2024, 4:05 PM EDT - 5 months ago

GeneDx to Participate in Fall Investor Conferences

Jul 30, 2024, 9:02 PM EDT - 6 months ago

GeneDx Holdings Corp. (WGS) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 4:05 PM EDT - 6 months ago

GeneDx Reports Second Quarter 2024 Financial Results and Business Highlights

Jul 30, 2024, 4:05 PM EDT - 6 months ago

GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients

Jul 11, 2024, 4:05 PM EDT - 6 months ago

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024

Jun 21, 2024, 1:58 PM EDT - 7 months ago

Stock Ideas Amid Investor Optimism

FTEL GE VST

Jun 10, 2024, 8:30 AM EDT - 7 months ago

GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

Jun 6, 2024, 7:00 AM EDT - 8 months ago

GeneDx Holdings: Mapping A Path To Leadership In Pediatric Genetic Testing

Jun 5, 2024, 7:00 AM EDT - 8 months ago

GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

May 22, 2024, 4:05 PM EDT - 8 months ago

GeneDx to Participate in Upcoming Investor Conferences

Apr 29, 2024, 9:42 PM EDT - 9 months ago

GeneDx Holdings Corp. (WGS) Q1 2024 Earnings Call Transcript

Apr 29, 2024, 4:05 PM EDT - 9 months ago

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

Apr 23, 2024, 8:30 AM EDT - 9 months ago

GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset

Apr 4, 2024, 4:05 PM EDT - 10 months ago

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

Mar 14, 2024, 8:30 AM EDT - 11 months ago

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

Feb 26, 2024, 4:05 PM EST - 11 months ago

GeneDx to Participate in 44th Annual Cowen Health Care Conference

Feb 20, 2024, 6:20 PM EST - 11 months ago

GeneDx Holdings Corp. (WGS) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 4:26 PM EST - 11 months ago

GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024

Feb 1, 2024, 4:30 PM EST - 1 year ago

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024

Jan 8, 2024, 8:55 AM EST - 1 year ago

GeneDx Announces Preliminary 2023 Financial Results

Dec 1, 2023, 8:30 AM EST - 1 year ago

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

Nov 28, 2023, 4:05 PM EST - 1 year ago

GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference

Nov 4, 2023, 11:03 AM EDT - 1 year ago

GeneDx Holdings Corp. (WGS) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 4:05 PM EDT - 1 year ago

GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights

Oct 9, 2023, 4:05 PM EDT - 1 year ago

GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023

Aug 21, 2023, 7:00 AM EDT - 1 year ago

GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine